Carlos Lanusse - Concepedia

Author

Carlos Lanusse

Universidad Nacional del Centro de la Provincia de Buenos Aires ORCID

Also Known As

, C Devine, C E Lanusse, C LANUSSE, C Lanusse, C. E. LANUSSE, C. E. Lanusse, C. LANUSSE, C. Lanusse, C.E Lanusse

296

Publications

8.2K

Citations

H-Index

103

Concepts

All Affiliations

Universidad Nacional del Centro de la Provincia de Buenos Aires Centro Científico Tecnológico - Tandil Consejo Nacional de Investigaciones Científicas y Técnicas Centro Científico Tecnológico - San Juan McGill University

About

Carlos Lanusse is an author at Universidad Nacional del Centro de la Provincia de Buenos Aires specializing in medicine, pharmacology, and animal science.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	36	93	3.8K
2	Education	26	43	2K
3	Engineering	5	5	256
4	Health Sciences	4	4	107
5	Natural Sciences	4	4	146

Carlos Lanusse

174

Publications

6.8K

Citations

H-Index

Page 1

	Year	Citations
Comparative plasma disposition kinetics of ivermectin, moxidectin and doramectin in cattle Carlos Lanusse, A. Lifschitz, G. Virkel, Journal of Veterinary Pharmacology and Therapeutics Antiparasitic AgentVeterinary ResearchEducationLivestock HealthBioanalysis	1997	235
Comparative distribution of ivermectin and doramectin to parasite location tissues in cattle A. Lifschitz, G. Virkel, J. Sallovitz, Veterinary Parasitology Animal PhysiologyParasitic DiseaseAnimal ScienceZoonotic DiseasePathogenesis	2000	193
Drug transfer into target helminth parasites L.I. Alvarez, M. L. MOTTIER, Carlos Lanusse Trends in Parasitology MedicineParasite ControlAntiparasitic AgentsHelminth InfectionPharmacology	2007	115
Ivermectin disposition kinetics after subcutaneous and intramuscular administration of an oil-based formulation to cattle A. Lifschitz, G. Virkel, A. Pis, Veterinary Parasitology Animal PhysiologyAnimal ScienceAnimal NutritionPhysiologyIvermectin Disposition Kinetics	1999	111
Antiviral effect of high-dose ivermectin in adults with COVID-19: A proof-of-concept randomized trial Alejandro Krolewiecki, A. Lifschitz, Matías Moragas, EClinicalMedicine High-dose IvermectinImmunologyAntiviral Drug DevelopmentAntiviral TherapyVirology	2021	98
Influence of verapamil on the pharmacokinetics of the antiparasitic drugs ivermectin and moxidectin in sheep Marcelo Beltrão Molento, A. Lifschitz, J. Sallovitz, Parasitology Research Animal PhysiologyAntiparasitic AgentAnimal ScienceAntiparasitic Drugs IvermectinPharmacology	2004	97
Drug transport mechanisms in helminth parasites: Passive diffusion of benzimidazole anthelmintics L. Mottier, Luis Álvarez, Laura Ceballos, Experimental Parasitology Passive DiffusionAntiparasitic AgentMedicineParasite ControlToxicology	2006	93
Altered drug influx/efflux and enhanced metabolic activity in triclabendazole-resistant liver flukes L.I. Alvarez, Hugo Solana, M. L. MOTTIER, Parasitology	2005	90
MODULATION OF THE P-GLYCOPROTEIN-MEDIATED INTESTINAL SECRETION OF IVERMECTIN: IN VITRO AND IN VIVO ASSESSMENTS M. Ballent, A. Lifschitz, G. Virkel, Drug Metabolism and Disposition	2005	89
Relationship between increased albendazole systemic exposure and changes in single nucleotide polymorphisms on the β-tubulin isotype 1 encoding gene in Haemonchus contortus Virginie Barrère, Luis Álvarez, Gonzalo Suárez, Veterinary Parasitology BiologyGenetic DisorderMedicineGeneticsAlbendazole Systemic Exposure	2011	88

Page 1